Tamsulosin Hydrochloride and Deflazacort Capsules 0.4/30 mg TASMULINE DFZ is a highly effective combination therapy formulated with Tamsulosin Hydrochloride (0.4 mg PR) and Deflazacort (30 mg). This medication is designed to provide dual benefits for patients suffering from urinary tract symptoms caused by Benign Prostatic Hyperplasia (BPH) and inflammatory conditions requiring corticosteroid support. Tamsulosin Hydrochloride is a selective alpha-1 adrenergic receptor blocker that relaxes the smooth muscles of the prostate and bladder neck, allowing urine to pass more easily. Deflazacort is a glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties, used to manage inflammation and reduce swelling in various body tissues. By combining these two potent ingredients, TASMULINE DFZ provides comprehensive management of prostate-related urinary problems and inflammatory disorders, improving patient comfort and quality of life. This medication is manufactured under strict quality standards to ensure safety, potency, and consistent therapeutic performance. Uses TASMULINE DFZ is indicated for the management of multiple conditions where urinary obstruction and inflammation coexist or require simultaneous treatment. The primary uses include: Benign Prostatic Hyperplasia (BPH): Helps relieve symptoms such as frequent urination, weak urine stream, incomplete bladder emptying, and nocturia (excessive urination at night). Urinary Retention or Difficulty in Urination: Tamsulosin improves urine flow by relaxing the muscles of the prostate and bladder neck, reducing pressure on the urethra. Inflammatory Conditions: Deflazacort helps manage inflammation associated with BPH, arthritis, respiratory disorders, and other chronic inflammatory diseases. Post-Surgical Inflammation in the Prostate or Urinary Tract: Reduces swelling and promotes faster healing after urological procedures. Pain and Swelling Management: The anti-inflammatory properties of Deflazacort make TASMULINE DFZ beneficial in reducing pain, tenderness, and tissue inflammation associated with prostate and urinary tract issues. This dual-action therapy offers both symptom relief and anti-inflammatory control, making it a versatile option for men with complex urinary or inflammatory conditions. Benefits Dual Therapeutic Action: Combines the benefits of an alpha-blocker and corticosteroid, targeting both urinary flow obstruction and inflammation simultaneously. Improved Urine Flow: Tamsulosin relaxes the prostate and bladder muscles, making urination easier and more comfortable. Reduces Prostate-Related Swelling: Deflazacort decreases inflammation and edema in the prostate gland, reducing discomfort and improving bladder function. Enhanced Symptom Control: Provides effective relief from BPH symptoms such as frequent urination, urgency, and incomplete emptying. Prevents Complications: Helps lower the risk of urinary tract infections and bladder damage caused by prolonged urinary retention. Anti-Inflammatory and Immunomodulatory Effect: Deflazacort’s corticosteroid properties help control inflammation in tissues, offering systemic relief in cases of swelling or immune-related conditions. Improved Quality of Life: Regular use as prescribed enhances urinary comfort, sleep quality, and overall daily activity levels for men with prostate-related symptoms. Well-Tolerated Formulation: The controlled-release (PR) formulation of Tamsulosin ensures smooth and consistent therapeutic action with minimal side effects. Side Effects Like any medication, TASMULINE DFZ may cause side effects, although not everyone experiences them. Most side effects are mild and temporary. Common side effects include: Dizziness or lightheadedness (especially after standing up) Nasal congestion or runny nose Headache or fatigue Nausea or mild stomach upset Fluid retention or swelling (due to corticosteroid) Increased appetite or mild weight gain Mood changes or sleep disturbances Rare but serious side effects may include: Irregular heartbeat or chest pain Blurred vision Persistent sore throat or signs of infection Unusual weakness or fatigue Elevated blood sugar levels If any severe side effects occur, discontinue the medication and seek immediate medical attention.
| Active Ingredients | Tamsulosin Hydrochloride 0.4 mg PR & Deflazacort 30 mg |
| Package SIZE | 1X10 Capsules |
| Manufactured By | Steris Healthcare Pvt Ltd |
| Storage | Store In A Cool & Dry Place |
| Brand Name: | TASMULINE DFZ |
| Dosage | As Directed By the Physician |
| Country of origin | INDIA |